Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance.

Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance. — المؤلف: Xu, Haiyan — Thoracic cancer 20200630

المؤلف
Xu, Haiyan
النشر
Thoracic cancer 20200630
الوصف
1096-1102 p.
الموضوعات
Adult؛ Aged؛ Anaplastic Lymphoma Kinase؛ Antineoplastic Agents؛ Carcinoma, Non-Small-Cell Lung؛ Crizotinib؛ Disease Progression؛ Drug Resistance, Neoplasm